Respiratory Medicine
Volume 97, Issue 1 , Pages 46-50 , January 2003

Effects by 8-bromo-cyclicAMP on basal and organic dust-induced release of interleukin-6 and interleukin-8 in A549 human airway epithelial cells

  • K BURVALL

      Affiliations

    • National Institute for Working Life, Stockholm, Sweden
    • ,
  • L PALMBERG

      Affiliations

    • The National Institute of Environmental Medicine, Lung- and Allergy Research, Karolinska Institute, Stockholm, Sweden
    • ,
  • K LARSSON

      Affiliations

    • The National Institute of Environmental Medicine, Lung- and Allergy Research, Karolinska Institute, Stockholm, Sweden

Received 9 January 2002 ,Accepted 27 May 2002.

References 

    REFERENCES
  1. Larsson K, Eklund A, Hansson L-O, Isaksson B-M, Malmberg P. Swine dust causes intense airways inflammation in healthy subjects. Am J Crit Care Med. 1994;150:973–977
  2. Wang Z, Larsson K, Palmberg L, Malmberg P, Larsson P, Larsson L. Inhalation of swine dust induces cytokine release in the upper and lower airways. Eur Respir J. 1997;10:381–387
  3. Palmberg L, Larsson B-M, Malmberg P, Larsson K. Induction of IL-8 production in human alveolar macrophages and human bronchial epithelial cells in vitro by swine dust. Thorax. 1998;53:260–264
  4. Wang Z, Malmberg P, Ek A, Larsson K, Palmberg L. Swine dust induces cytokine secretion from human epithelial cells and alveolar macrophages. Clin Exp Immunol. 1999;115:6–12
  5. Sandström T, Bjermer L, Rylander R. Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid. Eur Respir J. 1992;5:992–996
  6. Wang Z, Malmberg P, Larsson B-M, Larsson K, Larsson L, Saraf A. Exposure to bacteria in swine-house dust and acute inflammatory reactions in humans. Am J Respir Crit Care Med. 1996;154:1261–1266
  7. Zhang H, Kim Y, Govindarajan A. Effect of adrenoceptors on endotoxin-induced cytokines and lipid peroxidation in lung explant. Am J Respir Crit Care Med. 1999;160:1703–1710
  8. Hallsworth M, Twort C, Lee T, Hirst S. β2-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells. Br J Pharmacol. 2001;132:729–741
  9. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Viewpoint Immuno Today. 1997;18:428–432
  10. Xing Z, Gauldie J, Cox G. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998;101:311–320
  11. Keller TK, Wanagat J, Ershler W. Molecular and cellular biology of interleukin-6 and its receptor. Front Biosci. 1996;1:340–357
  12. Ben–Baruch A, Michiel DF, Oppenheim J. Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem. 1995;270:11703–11706
  13. Leiber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continous tumor cell line from human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976;17:62–70
  14. Ek A, Larsson K, Siljerud S, Palmberg L. Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages. Allergy. 1999;54:691–699
  15. Fuhrmann M, Jahn H-U, Seybold J. Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cells. Am J Respir Cell Mol Biol. 1999;20:292–302
  16. Linden A. Increased interleukin-8 release by beta-adrenoceptor activation in human transformed bronchial epithelial cells. Br J Pharmacol. 1996;119:402–406
  17. Holtmann H, Winzen R, Holland P. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol. 1999;19:6742–6753
  18. Zidek Z. Adenosine-cyclicAMP pathways and cytokine expression. Eur Cytokine Network. 1999;10:319–328
  19. Sitaraman S, Merlin D, Wang L. Neutrophil-epithelial crosstalk at the interstitial lumenal surface mediated by reciprocal secretion of adenosin and IL-6. J Clin Invest. 2001;107:861–869
  20. Haddad JJ, Land S, Tarnow-Mordi W. Immunopharmacological potential of selective phosphodiesterase inhibition. J Pharmacol Exp Ther. 2002;300:559–566
  21. Lien E, Ingalls RR. Toll-like receptors. Crit Care Med. 2002;30:S1–S11
  22. Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med. 2002;195:559–570
  23. Smirnova I, Poltorak A, Chan E, McBride C, Beutler B. Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4). Genome Biol. 2000;1:1–10

PII: S0954-6111(02)91415-0

doi: 10.1053/rmed.2002.1415

Respiratory Medicine
Volume 97, Issue 1 , Pages 46-50 , January 2003

Article Tools